Search

everythinglearnresearchcommunity

for

Search:↓

Itraconazole-loaded nanoparticles are more effective and less toxic for treating fungal infections than conventional oral itraconazole.

Oral minoxidil may effectively treat hair loss from chemotherapy.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

OCIAD2 and DCN genes affect hair growth in goats by having opposite effects on a growth signaling pathway and inhibiting each other.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Ethinylestradiol/Chlormadinone Acetate is a safe and effective birth control pill that also helps regulate menstrual cycles, reduces period pain, and treats certain skin and hair conditions.

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

Certain genetic variations can make people more likely to experience hair loss and low white blood cell count from azathioprine.

Nurses are exposed to chemotherapy drugs, risking health issues like hair loss, so protective gear and monitoring are needed.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

More research is needed to understand chemotherapy-induced hair loss and its phases.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

A substance called sodium zinc dihydrolipoylhistidinate can significantly reduce hair loss caused by chemotherapy in rats.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

High-dose methotrexate can cause severe skin and nail issues.